Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
33.32
+0.46 (1.40%)
At close: Dec 5, 2025, 4:00 PM EST
33.55
+0.23 (0.69%)
After-hours: Dec 5, 2025, 7:12 PM EST
Axogen Employees
As of December 31, 2024, Axogen had 452 total employees, including 451 full-time and 1 part-time employees. The number of employees increased by 24 or 5.61% compared to the previous year.
Employees
452
Change (1Y)
24
Growth (1Y)
5.61%
Revenue / Employee
$475,020
Profits / Employee
-$4,639
Market Cap
1.54B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AXGN News
- 2 days ago - Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) - GlobeNewsWire
- 2 days ago - FDA approves Axogen's nerve repair graft - Reuters
- 5 days ago - Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen - Seeking Alpha
- 4 weeks ago - Wasatch Micro Cap Value Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 5 weeks ago - Axogen, Inc. (AXGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Axogen, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN - Business Wire
- 2 months ago - AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire